[1]王艳秋.黄葵胶囊联合醋酸泼尼松治疗原发性肾病综合征的疗效[J].医学信息,2020,33(17):168-169,172.[doi:10.3969/j.issn.1006-1959.2020.17.051]
　WANG Yan-qiu.The Effect of Huangkui Capsule Combined with Prednisone Acetate in the Treatment of Primary Nephrotic Syndrome[J].Medical Information,2020,33(17):168-169,172.[doi:10.3969/j.issn.1006-1959.2020.17.051]
点击复制

黄葵胶囊联合醋酸泼尼松治疗原发性肾病综合征的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年17期
页码:
168-169,172
栏目:
中医中药
出版日期:
2020-09-01

文章信息/Info

Title:
The Effect of Huangkui Capsule Combined with Prednisone Acetate in the Treatment of Primary Nephrotic Syndrome
文章编号:
1006-1959（2020）17-0168-03
作者:
王艳秋
（佳木斯市中心医院肾内科，黑龙江 佳木斯 154002）
Author(s):
WANG Yan-qiu
(Department of Nephrology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
黄葵胶囊; 醋酸泼尼松; 原发性; 肾病综合征
Keywords:
Huangkui capsule; Prednisone acetate; Primary; Nephrotic syndrome
分类号:
R692
DOI:
10.3969/j.issn.1006-1959.2020.17.051
文献标志码:
A
摘要:
目的 观察黄葵胶囊联合醋酸泼尼松治疗原发性肾病综合征临床疗效。方法 选取2018年8月~2019年8月在我院诊治的96例原发性肾病综合征患者为研究对象，采用随机数字表法分为对照组和观察组，各48例。对照组采用醋酸泼尼松治疗，观察组在醋酸泼尼松治疗基础上给予黄葵胶囊治疗，比较两组临床总有效率、治疗前后肾功能指标[尿素氮（BUN）、24h尿蛋白定量、血肌酐（SCr）]、血脂指标[胆固醇（CHO）、甘油三酯（TG）、低密度脂蛋白（LDL）]、血浆白蛋白以及临床不良反应（失眠、高血糖、药源性高血压、恶心）发生情况。结果 观察组临床治疗总有效率为93.75%，高于对照组的81.25%，差异有统计学意义（P＜0.05）；治疗后两组BUN、24h尿蛋白定量、SCr、CHO、TG、LDL均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；治疗后两组血浆白蛋白均高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组临床不良反应发生率为8.33%，与对照组的10.41%比较，差异无统计学意义（P＞0.05）。结论 黄葵胶囊联合醋酸泼尼松治疗原发性肾病综合征有效率高，患者肾功能改善明显，可一定程度降低血脂，且临床不良反应少，联合治疗安全可靠。
Abstract:
Objective To observe the clinical efficacy of Huangkui capsule combined with prednisone acetate in the treatment of primary nephrotic syndrome.Methods A total of 96 patients with primary nephrotic syndrome who were diagnosed and treated in our hospital from August 2018 to August 2019 were selected as the research objects. They were divided into control group and observation group by random number table method, with 48 cases in each group. The control group was treated with prednisone acetate, and the observation group was treated with Huangkui capsules on the basis of prednisone acetate treatment. The total clinical effective rate and renal function indexes before and after treatment were compared between the two groups [urea nitrogen （BUN）, 24h urine protein quantification, Serum creatinine （SCr）], blood lipid indexes [cholesterol （CHO）, triglycerides （TG）, low-density lipoprotein （LDL）], plasma albumin, and clinical adverse reactions （insomnia, hyperglycemia, drug-induced hypertension, nausea） occurs.Results The total effective rate of clinical treatment in the observation group was 93.75%, which was higher than 81.25% in the control group,the difference was statistically significant （P＜0.05）; after treatment, the two groups had low BUN, 24h urine protein quantification, SCr, CHO, TG, and LDL before treatment, and the observation group was lower than the control group, the difference was statistically significant （P＜0.05）; after treatment, the plasma albumin of the two groups was higher than before treatment, and the observation group was higher than the control group, the difference was statistically significant （P＜0.05）; The incidence of clinical adverse reactions in the observation group was 8.33%, which was not statistically significant compared with 10.41% in the control group （P＞0.05）.Conclusion Huangkui capsule combined with prednisone acetate had a high effective rate in the treatment of primary nephrotic syndrome. The patient’s renal function was improved significantly, blood lipids could be reduced to a certain extent, and clinical adverse reactions were few. The combined treatment was safe and reliable.

参考文献/References:

[1]胡姬婷.百令胶囊联合应用低分子肝素治疗儿童原发性肾病综合征的临床疗效分析[J].中国实用医药,2016,11(27):172-173.[2]张桂月,王凤君,关美玉.低分子肝素钙联合肾炎康复片对原发性肾病综合征的治疗效果观察[J].当代医学,2016,22(29):150-151.[3]孙宏伟.金水宝胶囊联合替米沙坦治疗原发性肾病综合征患者的临床疗效[J].中国药物经济学,2016(2):49-50.[4]刘姝.黄芪注射液治疗原发性肾病综合征的临床疗效观察[J].中医药学报,2014,42(1):134-136.[5]孙宗成.中西医结合治疗原发性肾病综合症27例的疗效观察[J].临床合理用药杂志,2014,17(35):48-49.

相似文献/References:

[1]谢小街,黄凤梅,王满琴,等.氯沙坦钾片联合黄葵胶囊和贝前列素钠片对腹膜透析患者腹透液蛋白丢失的影响[J].医学信息,2019,32(24):136.[doi:10.3969/j.issn.1006-1959.2019.24.048]
　XIE Xiao-jie,HUANG Feng-mei,WANG Man-qin,et al.Effect of Losartan Potassium Tablets,Huangkui Capsules,and Beprost Sodium Tablets on Peritoneal Fluid Protein Loss in Patients with Peritoneal Dialysis[J].Medical Information,2019,32(17):136.[doi:10.3969/j.issn.1006-1959.2019.24.048]

更新日期/Last Update: 1900-01-01